Researchers also found that inhibition of RSK2 by CF-X9, a RSK2 inhibitor discovered by virtual screening, hindered the cell growth in BRAF inhibitor-resistant melanoma cells (Zhang et al., 2019). This evidence concerns the gene BRAF and melanoma.